<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2017041712830N21</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-06-29</date_registration>
      <primary_sponsor>Vice chancellor for research of Bushehr University of Medical Sciences</primary_sponsor>
      <public_title>The effect of remote ischemic preconditioning in prevention of delirium in patient with cardiopulmonary bypass</public_title>
      <acronym></acronym>
      <scientific_title>The effect of remote ischemic preconditioning in prevention of delirium in patient with cardiopulmonary bypass</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/12847</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Prevention, Other design features: Randomization by using Excel table.</study_design>
      <phase>N/A</phase>
      <hc_freetext>delirium.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: A checklist that investigates the psychological status of patients will be filled the night before open heart surgery. The occurrence of delirium is investigated by questionnaire from the night before surgery daily until 5 days after the operation. Assessing delirium will be done in 18-20 pm. The type, dosage and time of using medication (for example haloperidol if necessary) will also be recorded in the questionnaire. In remote ischemic preconditioning technique, an inflated blood pressure cuff, 9-12 cm wide, will be used after induction of anesthesia which will be closed at the top of participants’arm. Pressure of cuff is 200 mm Hg. Duration of use of inflated cuff is five minutes and after that cuff will be emptied in five minutes. The intervention will be done in three five-minute cycles and totally takes 30 minutes. During the anesthesia induction phase, medications such as Etomidate, which cannot induce remote preconditioning ischemic condition, will be used . After ECG, SPO2 and arterial line monitoring, induction of anesthesia starts. The method of anesthesia induction is considered by medications including Etomidate + Sufentanil+Midazolam. After intubating and placing CVP, patients are maintained by removal of inhaled medications Isoflurane and Sevoflurane and application of infusion of Sufentanil + Midazolam+ Atracurium. All patients receive 100% oxygen during anesthesia step. In anesthesia, patients candidate for open heart surgery require embedded arterial line (mostly from the left hand which induces no cardiovascular problems) and intravenous lines are inserted in the other hand. Cuff will be closed on another hand. All intravenous lines will be taken in the same hand with arterial lines. This intervention will be done under supervision of heart anesthesiologist. Intervention 2: Control Group: In this group, alsothe questionnaire in the night before surgery and daily to 5 days after surgery would be filled. In this group, after induction of anesthetic, preconditioning Ischemic method wouldn’t be used. The method and the use of anesthetic drugs in this group is similar to intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Faezeh Jahanpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Bushehr University of Medical Sciences</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 77 3332 8598</telephone>
        <email>f.jahanpour@bpums.ac.irfa_jahanpour@yahoo.com</email>
        <affiliation>Bushehr University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Faezeh Jahanpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Bushehr University of Medical Sciences</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 77 3332 8598</telephone>
        <email>f.jahanpour@bpums.ac.ir fa_jahanpour@yahoo.com</email>
        <affiliation>Bushehr University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Major inclusion criteria: candidates for elective cardiopulmonary bypass surgery; 55-70 years old patients؛ patients with EF greater than 35% (Severe LV dysfunction). Major  exclusion criteria: Reexploration (Patients who return to  operating room  after heart surgery due to excessive bleeding)؛ embedded IABP (embedded balloon pump in the operating room or the ICU because of LV dysfunction؛ patients with acute MI (patients with myocardial infarction during previous week)؛ DM؛ history of stroke؛ upper extremity peripheral vascular problems؛ unwillingness to continue the participation, no initial consent؛ transfer to other medical centers؛ psychiatric drugs؛ history of psychiatric disorders such as psychosis, mental retardation؛ presence of ST changes during operation</inclusion_criteria>
      <agemin>55 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F05</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Postoperative delirium</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: A checklist that investigates the psychological status of patients will be filled the night before open heart surgery. The occurrence of delirium is investigated by questionnaire from the night before surgery daily until 5 days after the operation. Assessing delirium will be done in 18-20 pm. The type, dosage and time of using medication (for example haloperidol if necessary) will also be recorded in the questionnaire. In remote ischemic preconditioning technique, an inflated blood pressure cuff, 9-12 cm wide, will be used after induction of anesthesia which will be closed at the top of participants’arm. Pressure of cuff is 200 mm Hg. Duration of use of inflated cuff is five minutes and after that cuff will be emptied in five minutes. The intervention will be done in three five-minute cycles and totally takes 30 minutes. During the anesthesia induction phase, medications such as Etomidate, which cannot induce remote preconditioning ischemic condition, will be used . After ECG, SPO2 and arterial line monitoring, induction of anesthesia starts. The method of anesthesia induction is considered by medications including Etomidate + Sufentanil+Midazolam. After intubating and placing CVP, patients are maintained by removal of inhaled medications Isoflurane and Sevoflurane and application of infusion of Sufentanil + Midazolam+ Atracurium. All patients receive 100% oxygen during anesthesia step. In anesthesia, patients candidate for open heart surgery require embedded arterial line (mostly from the left hand which induces no cardiovascular problems) and intravenous lines are inserted in the other hand. Cuff will be closed on another hand. All intravenous lines will be taken in the same hand with arterial lines. This intervention will be done under supervision of heart anesthesiologist.</i_keyword>
      <i_keyword>Control Group: In this group, alsothe questionnaire in the night before surgery and daily to 5 days after surgery would be filled. In this group, after induction of anesthetic, preconditioning Ischemic method wouldn’t be used. The method and the use of anesthetic drugs in this group is similar to intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Delirium. Timepoint: Before the intervention, one to five days after the intervention. Method of measurement: The checklist of delirium(NEECHAM).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research of Bushehr University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-03-13</approval_date>
        <contact_name>Ethics committee of Bushehr University of Medical Sciences</contact_name>
        <contact_address>Bushehr University Of Medical Sciences, Next to the hospital Salman Farsi, Sabzabad,Bushehr Bushehr  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
